Bank of New York Mellon’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
55,251
+110
| +0.2% | +$582 | ﹤0.01% | 3795 |
|
|
2025
Q1 | $449K | Buy |
55,141
+1,924
| +4% | +$15.7K | ﹤0.01% | 3485 |
|
|
2024
Q4 | $681K | Buy |
53,217
+114
| +0.2% | +$1.46K | ﹤0.01% | 3344 |
|
|
2024
Q3 | $569K | Sell |
53,103
-19,586
| -27% | -$210K | ﹤0.01% | 3436 |
|
|
2024
Q2 | $576K | Sell |
72,689
-34,919
| -32% | -$277K | ﹤0.01% | 3499 |
|
|
2024
Q1 | $1.72M | Sell |
107,608
-9,070
| -8% | -$145K | ﹤0.01% | 2839 |
|
|
2023
Q4 | $1.6M | Sell |
116,678
-11,094
| -9% | -$152K | ﹤0.01% | 2942 |
|
|
2023
Q3 | $1.87M | Buy |
127,772
+11,571
| +10% | +$169K | ﹤0.01% | 2848 |
|
|
2023
Q2 | $1.98M | Buy |
116,201
+59,505
| +105% | +$1.01M | ﹤0.01% | 2843 |
|
|
2023
Q1 | $792K | Buy |
56,696
+160
| +0.3% | +$2.24K | ﹤0.01% | 3236 |
|
|
2022
Q4 | $373K | Hold |
56,536
| – | – | ﹤0.01% | 3694 |
|
|
2022
Q3 | $298K | Hold |
56,536
| – | – | ﹤0.01% | 3839 |
|
|
2022
Q2 | $269K | Sell |
56,536
-49,832
| -47% | -$237K | ﹤0.01% | 3937 |
|
|
2022
Q1 | $902K | Buy |
106,368
+33,375
| +46% | +$283K | ﹤0.01% | 3374 |
|
|
2021
Q4 | $874K | Buy |
72,993
+1,535
| +2% | +$18.4K | ﹤0.01% | 3458 |
|
|
2021
Q3 | $1.27M | Buy |
71,458
+11,024
| +18% | +$195K | ﹤0.01% | 3259 |
|
|
2021
Q2 | $1.24M | Buy |
60,434
+48,628
| +412% | +$998K | ﹤0.01% | 3276 |
|
|
2021
Q1 | $234K | Sell |
11,806
-1,216
| -9% | -$24.1K | ﹤0.01% | 4001 |
|
|
2020
Q4 | $242K | Buy |
13,022
+3,774
| +41% | +$70.1K | ﹤0.01% | 3913 |
|
|
2020
Q3 | $233K | Buy |
+9,248
| New | +$233K | ﹤0.01% | 3794 |
|